Abstract
Patients with chronic kidney disease (CKD) often suffer from iron deficiency anemia necessitating treatment with intravenous iron. This study was designed to assess the safety of iron isomaltoside 1000 (Monofer) in CKD patients. The secondary objective was to assess its effect on iron deficiency anemia.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Indian Journal of Nephrology |
| Vol/bind | 24 |
| Udgave nummer | 5 |
| Sider (fra-til) | 589-96 |
| Antal sider | 8 |
| ISSN | 0971-4065 |
| Status | Udgivet - 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS